The NACP Phase V (2021–2026) has adopted a 95-95-95 target for HIV. This means:
- A 95% of people living with HIV know their status, 95% of diagnosed receive ART, 95% of those on ART achieve viral suppression ✓
- B 95% reduction in new infections, 95% reduction in AIDS-related deaths, 95% coverage of PMTCT
- C 95% of high-risk groups are tested, 95% linkage to care, 95% retention in care
- D 95% ART coverage, 95% viral load testing, and 95% of mothers on Option B+
Explanation
The UNAIDS 95-95-95 treatment cascade target, adopted by NACP Phase V, requires: (1) 95% of all people living with HIV know their HIV status; (2) 95% of those who know their status are on antiretroviral therapy; (3) 95% of those on ART achieve and maintain viral suppression (<200 copies/mL). Achieving all three 95s would result in 86% of all people living with HIV being virally suppressed, effectively ending HIV as a public health threat by 2030.
Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.